Weekly Administration of (bi-)Daily Oral Docetaxel in Combination With Ritonavir.

Next Previous
Trial Profile

Weekly Administration of (bi-)Daily Oral Docetaxel in Combination With Ritonavir.

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 11 Oct 2017

At a glance

  • Drugs Docetaxel/ritonavir (Primary)
  • Indications Advanced breast cancer; Bladder cancer; Cancer; Gastric cancer; Head and neck cancer; Non-small cell lung cancer; Oesophageal cancer; Ovarian cancer; Prostate cancer
  • Focus Adverse reactions; Pharmacogenomic

    • Most Recent Events

    • 23 Dec 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
    • 23 Dec 2010 Actual initiation date changed from Aug 2010 to Sep 2010 as reported by ClinicalTrials.gov.
    • 17 Aug 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top